Single Dose Truvada Study
common.study.values.description
“Single Dose Truvada Study”
This study examines tenofovir (TFV) drug concentrations in adults one day after taking a single dose of TruvadaAR - a pill used to prevent and treat HIV infection. The results of this study will be used to improve the (efficacy/accuracy) of a white coat adherence (WCA) detection test - a blood test that can be used to indicate medication adherence. Participants will receive one dose of TruvadaAR, and provide 2 total samples of blood.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Tenofovir
pre- and post-dosing measurements of TFV and TFV-DP in plasma and PBMCs.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Single Observed Dose Administration of Truvada® to Establish Single Dose Pharmacokinetic Standards in Healthy Individuals
common.study.values.clinical-trial-id
NCT03719053
participant.views.study.view.id
av2jra
